Insider Transactions in Q1 2024 at Adapt Health Corp. (AHCO)
Insider Transaction List (Q1 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 18
2024
|
Jason A Clemens Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
128,380
+21.98%
|
-
|
Mar 12
2024
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
114,906
-0.99%
|
$1,149,060
$10.7 P/Share
|
Mar 11
2024
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
182,607
-0.78%
|
$2,008,677
$11.03 P/Share
|
Mar 08
2024
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
52,487
-0.22%
|
$524,870
$10.98 P/Share
|
Mar 04
2024
|
Albert A. Prast Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
135,443
-42.79%
|
$1,354,430
$10.41 P/Share
|
Mar 04
2024
|
Albert A. Prast Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
135,443
+29.97%
|
$270,886
$2.69 P/Share
|
Mar 02
2024
|
Richard A Barasch Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,206
+4.48%
|
-
|
Feb 29
2024
|
Richard A Barasch Director |
SELL
Payment of exercise price or tax liability
|
Direct |
8,984
-2.04%
|
$89,840
$10.23 P/Share
|
Feb 05
2024
|
Josh Parnes Director |
BUY
Grant, award, or other acquisition
|
Direct |
231,853
+19.33%
|
-
|
Feb 05
2024
|
Shaw Rietkerk |
BUY
Grant, award, or other acquisition
|
Direct |
71,339
+23.09%
|
-
|
Feb 05
2024
|
Christine E. Archbold Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,536
+39.87%
|
-
|
Feb 05
2024
|
Jason A Clemens Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
139,112
+29.82%
|
-
|
Feb 05
2024
|
Jonathan B Bush General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
57,072
+50.0%
|
-
|
Feb 05
2024
|
Albert A. Prast Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
71,339
+28.26%
|
-
|
Jan 02
2024
|
Richard A Barasch Director |
SELL
Payment of exercise price or tax liability
|
Direct |
9,226
-2.06%
|
$64,582
$7.26 P/Share
|